West Chester, PA – Thursday, September 8th, 2022 /OrthoSpineNews/– Altus Spine, a leader in the development and innovation of medical devices used in spinal correction surgery, has received Notice of Allowance from the United States Patent and Trademark Office on its novel Pars Repair Device. This new device is aimed to provide a more elegant solution to treating spondylolysis resistant to conservative care. The Pars Repair Device is the result of over five years of continuous development, and the current effort extends and broadens the work of four prior patents developed by Dr. Carl Giordano of Atlantic Spine Specialists and Dr. Jeffrey Spivak at The Hospital for Joint Diseases, NYU.
“After many modifications and new innovations to this Pars Repair Device, I, along with the entire Altus Spine team, am thrilled to have received patent clearance on this life changing device,” said Michael Fitzgerald, Altus Spine President and CEO, “This collaboration with Drs. Giordano and Spivak has been an honor, and the resulting device is truly remarkable.”
The new patented Pars Repair Device provides an innovative solution for treating the symptomatic adolescent spondylolysis that is resistant to conservative care. The adult manifestation of this untreated adolescent condition is a symptomatic Isthmic Spondylolisthesis for which 50,000 fusions are done per year in the US. By treating the adolescent condition, the device intends to reduce the probability of adult Isthmic Spondylolisthesis. The current invention is designed to fill a clinical care void that exists in the treatment of these conditions.
Composed of a spinous process plate, a laminar plate, a sub-laminar hook, and a rod, the device has first and second fixation elements are configured to pass through the spinous process plate and the laminar plate, respectively. The rod anchored at the distal end to the third fixation element extends substantially perpendicular to the longitudinal axis of the rod, providing multi-planar fixation components.
“Although many techniques exist to repair a spondylolysis, none of the presently available techniques provide the segmental rigid multi-planar fixation that we are used to with other fracture fixation surgery,” said Dr. Giordano. “I personally have performed thousands of these fusion operations over the years for adult Isthmic Spondylolisthesis and I believe as this new Pars Repair Device enters into the field it could drastically change the paradigm for treating spondylolysis. I believe that this technique will become the standard of care for treatment of spondylolysis in both adolescents and adults,” Dr. Giordano explained.
To learn more about the newly patented Pars Repair Device, please reach out to email@example.com.
Based in West Chester, PA, Altus Spine is dedicated to creating the next generation of medical devices. Altus strives to improve patient care by designing and manufacturing products to meet the highest standards in an ever changing and evolving field. Implemented and used by over 100 hospitals across the United States, Altus is among the fastest growing spinal implant companies in the world. For additional information, or to inquire about distribution opportunities, please contact us at firstname.lastname@example.org.
Forward Looking Statements
All statements made in the above press release, with the exception of historical fact, may be forward-looking statements that include risk, uncertainty, and assumptions. These factors could cause Altus Spine’s results to differ from those predicted if they do not occur as expected. These uncertain factors include, but are not limited to: acceptance and clearance of the company’s surgical products and procedures, development of new products and procedures, innovations and alterations to existing products and procedures, clinical and statistical verification of the success using Altus Spine’s products, company’s ability to maintain and monitor inventory as it releases new products, its ability to hire and retain personnel, and any other risks stated in prior or subsequent news releases. Given the constantly changing market, readers are encouraged to not place undue reliance on forward-looking statements. Altus Spine assumes no obligation to update forward-looking statements as these changes occur, or as events and circumstances are altered, after the date they are posted.